The risky business of studying prognosis.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 23204219.
- Also identified by DOI 10.3899/jrheum.121360.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Prognosis studies provide important healthcare information. Clinicians use prognostic factors to predict disease progress, thus allowing individualization of disease management. Prognosis is the issue in many translational studies that aim to identify biomarkers to predict outcomes. In a clinical trial, researchers may use prognostic factors to sort patients into risk groups, to clarify the effects of a new therapeutic agent. Prognosis studies can have significant effects on clinical practice.
Medical subject headings
- Antibodies, Antiphospholipid
- Antiphospholipid Syndrome
- Antirheumatic Agents
- Hydroxychloroquine
- Lupus Erythematosus, Systemic